Streetbeat News

Stock Prices

FCFS

FirstCash Holdings (NYSE:FCFS) has seen a 22.07% decrease in short interest, now at 337 thousand shares or 1.13% of float, indicating a potential shift in market sentiment towards the stock. With a peer average short interest of 8.44%, FCFS's lower short interest suggests it is viewed more favorably than its peers. The decrease in short interest could signal a more bullish outlook among investors, despite not guaranteeing near-term stock price rise.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 6:30 pm

ZBH

Zimmer Biomet Holdings (NYSE:ZBH) has seen a decrease in short interest, now at 2.52% of its float, down 3.45% from the last report. With 4.11 million shares sold short, it would take about 2.27 days to cover all short positions. This decline in short interest could indicate a more bullish sentiment towards ZBH among investors. Compared to its peers, ZBH has a lower short interest percentage, with the average for its peer group being 4.15%.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 6:30 pm

COF

Over the past 15 years, Capital One Financial (NYSE:COF) has outperformed the market with an annualized return of 17.38%, turning a $1000 investment into $10,913.68. The company currently has a market capitalization of $50.89 billion.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 6:30 pm

WFRD

Weatherford International (NYSE:WFRD) has seen a decrease in short interest, now at 6.01% of its float, lower than its peer group average of 7.73%. This indicates a potential shift in market sentiment towards a more bullish outlook for WFRD, despite the short interest not directly predicting stock price movements.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 6:30 pm

DLTR

Over the past 20 years, Dollar Tree (NASDAQ:DLTR) has produced an average annual return of 13.52%, turning a $1000 investment into $12,622.38 today. With a current market capitalization of $30.47 billion, DLTR has outperformed the market by 5.97% on an annualized basis.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 6:30 pm

YTEN

Yield10 Bioscience Inc (NASDAQ:YTEN) stock fell 21% to $0.57 amid volatility after announcing its focus on advancing its Omega-3 Camelina program towards 2024 commercialization. The company completed contra season production in Chile, crucial for aquafeed and human nutrition. Yield10 is scaling up seed production, seeking partnerships, and navigating regulatory processes, including working with BioMar and deregulating Omega-3 Camelina in the US. Additionally, the company awaits a Nasdaq Hearings Panel decision on its listing status, expected within a month. Lake Street analyst Ben Klieve downgraded YTEN from Buy to Hold with a $0.5 price target.

Portfolio Pulse from Henry Khederian

February 08, 2024 | 6:26 pm

UBER

Citigroup analyst Ronald Josey has maintained a Buy rating on Uber Technologies (NYSE:UBER) and increased the price target from $75 to $83, indicating a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 6:18 pm

S

Recent options trading activity for SentinelOne (NYSE:S) indicates a bearish stance by significant investors, with a split sentiment of 42% bullish and 57% bearish. The trading activity suggests a target price range of $27.5 to $40.0. SentinelOne, a cloud-based cybersecurity company, saw its stock price slightly up at $28.26. Analyst ratings from Citigroup and BTIG offer mixed views, with target prices of $25 and $30, respectively.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 6:16 pm

ISRG

Recent options market activity indicates a bearish sentiment towards Intuitive Surgical (NASDAQ:ISRG), with a significant majority of trades being puts. The targeted price range for ISRG by whales is between $380.0 and $410.0. Despite this, expert analysts have set higher average target prices, suggesting a bullish outlook on the stock. Intuitive Surgical's current trading volume is 326,372, with a slight price decrease of -0.35%, and its stock price stands at $390.0. The company is a leader in robotic-assisted minimally invasive surgery, with a substantial global installation base of its da Vinci systems.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 6:16 pm

SNA

Snap-on Inc (NYSE:SNA) reported Q4 FY23 results with a 3.5% Y/Y sales increase to $1.197 billion, missing consensus estimates by $5 million. The revenue growth was attributed to organic sales, acquisition-related sales, and favorable foreign currency translation. Despite a revenue miss, EPS of $4.75 beat the consensus of $4.66. Operating earnings and gross profit also saw increases from the previous year. However, shares fell 8.9% following the announcement. The company anticipates FY24 capital expenditures of $100 million to $110 million and an effective income tax rate of 22% to 23%.

Portfolio Pulse from Lekha Gupta

February 08, 2024 | 6:16 pm